FDA approves Lilly's Olumiant for pediatric alopecia areata
The FDA approved Lilly's Olumiant (baricitinib) for pediatric patients 12 years and older with severe alopecia areata.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.